Similar to its effects on cancer cells, the inhibitory effect of CLT on ECs was due to its ability to inhibit MMPs expression and VEGF secretion by downregulating Runx2 activation of ECs, which may be associated with interference with BMP signaling in endothelial cells [64]. The gene discussed is VEGFA; the disease is cancer.